MENU
CTKB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cytek Biosciences (CTKB) Earnings Date & Reports

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells... Show more

A.I. Advisor
published Earnings

CTKB is expected to report earnings to fall 44.44% to -5 cents per share on November 04

Cytek Biosciences CTKB Stock Earnings Reports
Q3'26
Est.
$-0.05
Q2'26
Missed
by $0.01
Q1'26
Missed
by $0.05
Q4'25
Missed
by $0.32
Q3'25
Missed
by $0.01
The last earnings report on August 05 showed earnings per share of -9 cents, missing the estimate of -7 cents. With 338.11K shares outstanding, the current market capitalization sits at 705.81M.